Pages that link to "Q41005307"
Jump to navigation
Jump to search
The following pages link to 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins (Q41005307):
Displaying 50 items.
- Role of HMG-CoA Reductase Inhibitors in Neurological Disorders (Q22241432) (← links)
- Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells (Q24533532) (← links)
- Pleiotropic effects of statins (Q24647863) (← links)
- Are statins anti-inflammatory? (Q24792912) (← links)
- HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins (Q28344912) (← links)
- Pravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase (Q28362055) (← links)
- Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I (Q28366335) (← links)
- Dynamic partitioning of a glycosyl-phosphatidylinositol-anchored protein in glycosphingolipid-rich microdomains imaged by single-quantum dot tracking (Q30491186) (← links)
- Chemoprevention of melanoma (Q31104539) (← links)
- Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cells. (Q33323649) (← links)
- Salvaging the zone of stasis by simvastatin: an experimental study in rats (Q33495066) (← links)
- Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study (Q33691624) (← links)
- New insights into the pharmacodynamic and pharmacokinetic properties of statins. (Q33832848) (← links)
- Statins induce hypothrombotic states? (Q33868357) (← links)
- Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes (Q33882829) (← links)
- Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy (Q33960556) (← links)
- PPAR agonists as direct modulators of the vessel wall in cardiovascular disease (Q33996831) (← links)
- Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins? (Q34107300) (← links)
- Radiation as a risk factor for cardiovascular disease (Q34150728) (← links)
- Comparison of the post-embolization effects of tissue-plasminogen activator and simvastatin on neurological outcome in a clinically relevant rat model of acute ischemic stroke (Q34207727) (← links)
- Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis (Q34362144) (← links)
- Statins and ischemic stroke (Q34666839) (← links)
- Statins: mechanism of action and effects. (Q34687736) (← links)
- Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin (Q34773911) (← links)
- Isoprenoids as mediators of the biological effects of statins (Q34774535) (← links)
- Statins as immunomodulators (Q34786108) (← links)
- Vascular pleiotropy of statins: clinical evidence and biochemical mechanisms (Q35058227) (← links)
- Neuroprotection mediated by changes in the endothelial actin cytoskeleton. (Q35128290) (← links)
- Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model. (Q35128709) (← links)
- The lipid and non-lipid effects of statins (Q35153749) (← links)
- Statin use following intracerebral hemorrhage: a decision analysis (Q35170660) (← links)
- Endothelium as a target for anti-phospholipid antibodies and for therapeutical intervention (Q35172201) (← links)
- Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells (Q35189302) (← links)
- Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes (Q35200997) (← links)
- Thinking Intelligently About Therapy of Atherosclerosis (Q35587360) (← links)
- The many roles of statins in ischemic stroke (Q35595431) (← links)
- Statins in coronary bypass surgery: rationale and clinical use. (Q35604889) (← links)
- Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease (Q35634151) (← links)
- 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase (Q35654989) (← links)
- Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation (Q35675305) (← links)
- The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach (Q35744631) (← links)
- The effect of statin therapy in stroke outcome: a double blind clinical trial (Q35755104) (← links)
- The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. (Q35793178) (← links)
- Statins in solid organ transplantation: is there an immunosuppressive effect? (Q35804356) (← links)
- Simvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanism (Q36024850) (← links)
- Pleiotropic effects of statins: moving beyond cholesterol control (Q36025981) (← links)
- Statin mediated protection of the ischemic myocardium (Q36142655) (← links)
- Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities (Q36205039) (← links)
- Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol (Q36242351) (← links)
- Statins and bone metabolism (Q36395695) (← links)